Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudiesBryan Williams, A Stanley, Richard Hobbs et al.|The Lancet Diabetes & Endocrinology|2018Cited by 340